Further observations on the effect of topical progesterone on vulvar disease.
Follow-up studies have confirmed the beneficial effect of topical progesterone in the treatment of vulvar dystrophy, whether of the atrophic, hypertrophic or mixed variety, in both postmenopausal and premenarchal women. If pruritus is a major symptom, topical corticosteroids should be alternated with the progesterone preparation in order to obtain maximum results. Topical progesterone was also found to be useful in the treatment of labial agglutination in children.
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D005260:Female; D006801:Humans; D011374:Progesterone / Q000627:therapeutic use*; D011537:Pruritus / Q000188:drug therapy; D014845:Vulvar Diseases / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D011374:Progesterone